Guoqing Sui

1.2k citations
45 papers · 863 indexed · h-index 18
Topics
Thyroid Cancer Diagnosis and Treatment (13 papers)Nanoplatforms for cancer theranostics (8 papers)Thyroid and Parathyroid Surgery (7 papers)
Partner nations
ChinaCanadaHong Kong

In The Last Decade

Guoqing Sui

44 papers receiving 855 citations

Peers

Guoqing Sui
Comparison fields: 5 of 95
  • Endocrinology, Diabetes and Metabolism 288
  • Molecular Biology 251
  • Surgery 250
  • Biomedical Engineering 162
  • Cancer Research 159
Replace Jing Xiao with:
Jing Xiao China
Marwan Moussa United States
Baoding Chen China
Jinghui Lu China
Fan Fan China
Detao Yin China
David Ivancic United States
Maytê Bolean Brazil
Kazuya Kitamura Japan
Przemysław Majewski Poland
Guoqing Sui relative to Jing Xiao China Jing Xiao's profile →
Citations per field
00.5×6.3×
Jing Xiao · 1×
Citations per year

Countries citing papers authored by Guoqing Sui

Since Specialization
Citations

This map shows the geographic impact of Guoqing Sui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoqing Sui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoqing Sui more than expected).

Fields of papers citing papers by Guoqing Sui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoqing Sui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoqing Sui. The network helps show where Guoqing Sui may publish in the future.

Co-authorship network of co-authors of Guoqing Sui

This figure shows the co-authorship network connecting the top 25 collaborators of Guoqing Sui. A scholar is included among the top collaborators of Guoqing Sui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoqing Sui. Guoqing Sui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 4
4 3
5 2
6 3
7 7
8 4
9 10
10 5
11 15
12 2
13 18
14 11
15 7
16 37
17 43
18 21
19 5
20 66

About Guoqing Sui

Guoqing Sui is a scholar working on Endocrinology, Diabetes and Metabolism, Biomaterials and Reproductive Medicine, having authored 45 papers that have together received 863 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (13 papers), Nanoplatforms for cancer theranostics (8 papers) and Thyroid and Parathyroid Surgery (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (288 citations), Cancer Research (159 citations) and Surgery (250 citations). Guoqing Sui has collaborated with scholars based in China, Canada and Hong Kong. Frequent co-authors include Dengke Teng, Yuanqiang Lin, Qiang Luo, Hui Wang, Jiarui Du, Wenming Zhou, Yang Wang, Hong‐Dong Hao, Dan Jiao and Feng Guo. Their work appears in journals such as Acta Biomaterialia, International Journal of Biological Macromolecules and European Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026